Skip to main content

Want a detailed portfolio tracker?

Comparison Monopar Therapeutics (MNPR) with Competitors

Monopar Therapeutics (MNPR) industry is Biotechnology.

Free Cash Flow Yield
MNPR-2.32%
Industry-1.94%
Upside-0.37%
P/E
MNPR-28.38
Industry-18.88
Upside-949.99%
P/B
MNPR3.21
Industry4.70
Upside-31.71%